Tyler J Curiel (Tyler Curiel)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Histone Deacetylase

Muscle Invasive Bladder Cancer

Top Venues

Journal for immunotherapy of cancer

Cancer research

Aging and cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Dhan Chand, David A Savitsky, Shanmugarajan Krishnan, Gabriel Mednick, Chloe Delepine, Pilar Garcia-Broncano, Kah Teong Soh, Wei Wu, Margaret K Wilkens, Olga O Udartseva, Sylvia Vincent, Bishnu P Joshi, Justin G Keith, Mariana Manrique, Marilyn Marques, Antoine Tanne, Daniel L Levey, Haiyong Han, Serina Ng, Jackson Ridpath, Olivia Huber, Benjamin Morin, Claire Galand, Sean Bourdelais, Randi B Gombos, Rebecca Ward, Yu Qin, Jeremy D Waight, Matthew R Costa, Alvaro Sebastian-Yague, Nils-Petter Rudqvist, Malgorzata Pupecka-Swider, Vignesh Venkatraman, Andrew Slee, Jaymin M Patel, Joseph E Grossman, Nicholas S Wilson, Daniel D Von Hoff, Justin Stebbing, Tyler J Curiel, Jennifer S Buell, Steven J O'Day, Robert B Stein
Botensilimab, an Fc-enhanced anti-CTLA-4 antibody, is effective against tumors poorly responsive to conventional immunotherapy. Cancer discovery (2024)
Haiyan Bai, Alvaro S Padron, Yilun Deng, Yiji J Liao, Clare J Murray, Carlos Ontiveros, Suresh J Kari, Aravind Kancharla, Anand V R Kornepati, Myrna Garcia, Ryan Michael Reyes, Harshita B Gupta, Jose R Conejo-Garcia, Tyler J Curiel
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects. Journal for immunotherapy of cancer 11 (2) (2023)
Haiyan Bai, Alvaro S Padron, Yilun Deng, Yiji J Liao, Clare J Murray, Carlos Ontiveros, Suresh J Kari, Aravind Kancharla, Anand V R Kornepati, Myrna Garcia, Ryan Michael Reyes, Harshita B Gupta, Jose R Conejo-Garcia, Tyler J Curiel
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects. Journal for immunotherapy of cancer 11 (2) (2023)
Haiyan Bai, Alvaro S Padron, Yilun Deng, Yiji J Liao, Clare J Murray, Carlos Ontiveros, Suresh J Kari, Aravind Kancharla, Anand V R Kornepati, Myrna Garcia, Ryan Michael Reyes, Harshita B Gupta, Jose R Conejo-Garcia, Tyler J Curiel
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects. Journal for immunotherapy of cancer 11 (2) (2023)
Mary L Disis, Sarah F Adams, Jyoti Bajpai, Marcus O Butler, Tyler J Curiel, Shelley A Dodt, Laura Doherty, Leisha A Emens, Claire F Friedman, Margaret E Gatti-Mays, Melissa A Geller, Amir A Jazaeri, Veena S John, Katherine C Kurnit, John B Liao, Hader Mahdi, Anne Mills, Emese Zsiros, Kunle Odunsi
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. Journal for immunotherapy of cancer 11 (6) (2023)
Anand V R Kornepati, Cody M Rogers, Patrick Sung, Tyler J Curiel
The complementarity of DDR, nucleic acids and anti-tumour immunity. Nature 619 (7970) (2023)
Haiyan Bai, Alvaro S Padron, Yilun Deng, Yiji J Liao, Clare J Murray, Carlos Ontiveros, Suresh J Kari, Aravind Kancharla, Anand V R Kornepati, Myrna Garcia, Ryan Michael Reyes, Harshita B Gupta, Jose R Conejo-Garcia, Tyler J Curiel
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects. Journal for immunotherapy of cancer 11 (2) (2023)
Carlos O Ontiveros, Clare E Murray, Grace Crossland, Tyler J Curiel
Considerations and Approaches for Cancer Immunotherapy in the Aging Host. Cancer immunology research (2023)
Anand V R Kornepati, Jacob T Boyd, Clare E Murray, Julia Saifetiarova, Bárbara de la Peña, Cody M Rogers, Haiyan Bai, Alvaro S Padron, Yiji Liao, Carlos Ontiveros, Robert S Svatek, Robert Hromas, Rong Li, Yanfen Hu, José R Conejo-Garcia, Ratna K Vadlamudi, Weixing Zhao, Eloïse Dray, Patrick Sung, Tyler J Curiel
Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic Lethality. Cancer research 82 (11) (2022)
Sukeshi Patel Arora, Laura Tenner, John Sarantopoulos, Jay Morris, Qianqian Liu, Jenny A Mendez, Tyler J Curiel, Joel Michalek, Devalingam Mahalingam
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC). British journal of cancer 127 (6) (2022)
José R Conejo-Garcia, Tyler J Curiel
Belly Fat Weakens Immune Fitness. Cancer discovery 12 (8) (2022)
Juyeong Hong, Ji Hoon Lee, Zhao Zhang, Yanming Wu, Mei Yang, Yiji Liao, Richard de la Rosa, Jessica Scheirer, Douglas Pechacek, Nu Zhang, Zhenming Xu, Tyler J Curiel, Xi Tan, Tim Hui-Ming Huang, Kexin Xu
PRC2-mediated epigenetic suppression of type I IFN-STAT2 signaling impairs antitumor immunity in luminal breast cancer. Cancer research (2022)
Gunjan Mandal, Subir Biswas, Carmen M Anadon, Xiaoqing Yu, Chandler D Gatenbee, Sandhya Prabhakaran, Kyle K Payne, Ricardo A Chaurio, Alexandra L Martin, Patrick Innamarato, Carlos Moran Segura, Joseph Pidala, Carly M Harro, Jessica A Mine, Kimberly B Sprenger, Kristen E Rigolizzo, Xuefeng Wang, Tyler J Curiel, Paulo C Rodriguez, Alexander A R A Anderson, Ozlen Saglam, José R Conejo-Garcia
IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer. Cancer research 82 (5) (2022)
Clare Murray, Eva Galvan, Carlos Ontiveros, Yilun Deng, Haiyan Bai, Alvaro Souto Padron, Kathryn Hinchee-Rodriguez, Myrna G Garcia, Anand Kornepati, José R Conejo-Garcia, Tyler J Curiel
Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents. International journal of molecular sciences 23 (9) (2022)
Anand V R Kornepati, Ratna K Vadlamudi, Tyler J Curiel
Programmed death ligand 1 signals in cancer cells. Nature reviews. Cancer 22 (3) (2022)
Myrna G Garcia, Yilun Deng, Clare Murray, Ryan Michael Reyes, Alvaro Padron, Haiyan Bai, Aravind Kancharla, Harshita Gupta, Shai Shen-Orr, Tyler J Curiel
Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice. Aging and cancer 3 (1) (2022)
Myrna G Garcia, Yilun Deng, Clare Murray, Ryan Michael Reyes, Alvaro Padron, Haiyan Bai, Aravind Kancharla, Harshita Gupta, Shai Shen-Orr, Tyler J Curiel
Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice. Aging and cancer 3 (1) (2022)
Deyi Zhang, Ryan Michael Reyes, Erica Osta, Suresh Kari, Harshita B Gupta, Alvaro S Padron, Anand V R Kornepati, Aravind Kancharla, Xiujie Sun, Yilun Deng, Bogang Wu, Ratna K Vadlamudi, Rong Li, Robert S Svatek, Tyler J Curiel
Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy. Cancer medicine 10 (6) (2021)
Suzanne R Thibodeaux, Brian B Barnett, Srilakshmi Pandeswara, Shawna R Wall, Vincent Hurez, Vinh Dao, Lishi Sun, Benjamin J Daniel, Michael J Brumlik, Justin Drerup, Álvaro Padrón, Theresa L Whiteside, Ilona Kryczek, Weiping Zou, Tyler J Curiel
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Niannian Ji, Neelam Mukherjee, Zhen-Ju Shu, Ryan Michael Reyes, Joshua J Meeks, David J McConkey, Jonathan A Gelfond, Tyler J Curiel, Robert S Svatek
γδ T Cells Support Antigen-Specific αβ T cell-Mediated Antitumor Responses during BCG Treatment for Bladder Cancer. Cancer immunology research 9 (12) (2021)
Xiujie Sun, Bogang Wu, Huai-Chin Chiang, Hui Deng, Xiaowen Zhang, Wei Xiong, Junquan Liu, Aaron M Rozeboom, Brent T Harris, Eline Blommaert, Antonio Gómez, Roderic Espin Garcia, Yufan Zhou, Payal Mitra, Madeleine Prevost, Deyi Zhang, Debarati Banik, Claudine Isaacs, Deborah Berry, Catherine Lai, Krysta Chaldekas, Patricia S Latham, Christine A Brantner, Anastas Popratiloff, Victor X Jin, Ningyan Zhang, Yanfen Hu, Miguel Angel Pujana, Tyler J Curiel, Zhiqiang An, Rong Li
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599 (7886) (2021)
Bin Yuan, Curtis A Clark, Bogang Wu, Jing Yang, Justin M Drerup, Tianbao Li, Victor X Jin, Yanfen Hu, Tyler J Curiel, Rong Li
Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch. Journal for immunotherapy of cancer 9 (1) (2021)
Ryan Michael Reyes, Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler, Harshita B Gupta, Alvaro S Padron, Aravind Kancharla, Chenghao Zhang, Myrna Garcia, Anand V R Kornepati, Onur Boyman, Jose R Conejo-Garcia, Robert S Svatek, Tyler J Curiel
CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation. Journal for immunotherapy of cancer 9 (4) (2021)
Niannian Ji, Neelam Mukherjee, Ryan Michael Reyes, Jonathan Gelfond, Martin Javors, Joshua J Meeks, David J McConkey, Zhen-Ju Shu, Chethan Ramamurthy, Ryan Dennett, Tyler J Curiel, Robert S Svatek
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study. Journal for immunotherapy of cancer 9 (3) (2021)
Justin M Drerup, Yilun Deng, Sri Lakshmi Pandeswara, Álvaro S Padrón, Ryan Michael Reyes, Xinyue Zhang, Jenny Mendez, Aijie Liu, Curtis A Clark, Wanjiao Chen, José R Conejo-Garcia, Vincent Hurez, Harshita B Gupta, Tyler J Curiel
CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade. Cancer research 80 (22) (2020)